Terms: = Liver cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
323 results:
1. Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma.
Zhu M; Jin M; Zhao X; Shen S; Chen Y; Xiao H; Wei G; He Q; Li B; Peng Z
BMC Med; 2024 Apr; 22(1):165. PubMed ID: 38637772
[TBL] [Abstract] [Full Text] [Related]
2. The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis).
Taghizadeh M; Jafari-Koshki T; Jafarlou V; Raeisi M; Alizadeh L; Roosta Y; Matin S; Jabari R; Sur D; Karimi A
BMC Cancer; 2024 Apr; 24(1):484. PubMed ID: 38627675
[TBL] [Abstract] [Full Text] [Related]
3. Development of a short-term nutritional risk prediction model for hepatocellular carcinoma patients: a retrospective cohort study.
Yu J; Lam SK; He L; Wang P; Cao Y
Sci Rep; 2024 Feb; 14(1):3921. PubMed ID: 38365922
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract] [Full Text] [Related]
5. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
6. prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.
Iwaki M; Fujii H; Hayashi H; Toyoda H; Oeda S; Hyogo H; Kawanaka M; Morishita A; Munekage K; Kawata K; Tsutsumi T; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T
Clin Mol Hepatol; 2024 Apr; 30(2):225-234. PubMed ID: 38263684
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
9. Cross-talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis.
Ren C; Yang Z; Xu E; Kang X; Wang X; Sun Q; Wang C; Zhang L; Miao J; Luo B; Chen K; Liu S; Shen X; Lu X; Yin K; Wang M; Xia X; Guan W
Cancer Sci; 2024 Feb; 115(2):369-384. PubMed ID: 38050654
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of Sepsis-1, 2 and 3 for Predicting Mortality in Septic Patients of a Middle-Income Country: A Retrospective Observational Cohort Study.
Machado Lessa CL; Branchini G; Moreira Delfino I; Ramos Voos MH; Teixeira C; Hoher JA; Nunes FB
J Intensive Care Med; 2024 Apr; 39(4):349-357. PubMed ID: 37899601
[TBL] [Abstract] [Full Text] [Related]
11. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Comprehensive Nursing Based on Risk Factors in liver cancer Patients Accepted Intervention Therapy On Quality of Life and prognosis.
Pan W; Dai F
Altern Ther Health Med; 2024 Jan; 30(1):154-159. PubMed ID: 37773666
[TBL] [Abstract] [Full Text] [Related]
14. Timing of surgery in patients with synchronous colorectal cancer liver metastases undergoing neoadjuvant chemotherapy: a propensity score analysis.
Wang Y; Wen N; Xiong X; Lu J; Li B; Cheng N
World J Surg Oncol; 2023 Sep; 21(1):276. PubMed ID: 37658360
[TBL] [Abstract] [Full Text] [Related]
15. Palliative radiotherapy for hepatic tumors: a narrative review of indications and recommendations.
Pennock M; Klein J; Lock M
Ann Palliat Med; 2023 Nov; 12(6):1420-1446. PubMed ID: 37574583
[TBL] [Abstract] [Full Text] [Related]
16. c-met activation promotes extravasation of hepatocellular carcinoma cells into 3D-cultured hepatocyte cells in lab-on-a-chip device.
Bagci G; Comez D; Topel H; Yilmaz Y; Bagirsakci E; Gunes A; Batı Ayaz G; Tahmaz I; Bilgen M; Solmaz G; Pesen Okvur D; Atabey N
Biochim Biophys Acta Mol Cell Res; 2023 Dec; 1870(8):119557. PubMed ID: 37549739
[TBL] [Abstract] [Full Text] [Related]
17. Relationship between STAP1 methylation in peripheral blood T cells and the clinicopathological characteristics and prognosis of patients within 5-cm diameter HCC.
Sun L; Zhao X; Zhang H; Li G; Li N
Minerva Gastroenterol (Torino); 2024 Mar; 70(1):16-21. PubMed ID: 37526444
[TBL] [Abstract] [Full Text] [Related]
18. Loss of TP53 cooperates with c-met overexpression to drive hepatocarcinogenesis.
Zhou Y; Cui G; Xu H; Chun J; Yang D; Zhang Z; Yang L; Wang J; Wan M; Calvisi DF; Lin S; Chen X; Wang H
Cell Death Dis; 2023 Jul; 14(7):476. PubMed ID: 37500626
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Huang J; Wang ZG; Tao QF; Yang Y; Yuan SX; Gu FM; Liu H; Pan ZY; Jiang BG; Lau WY; Zhou WP
Front Immunol; 2023; 14():1198562. PubMed ID: 37483609
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of CalliSpheres® microspheres drug-eluting beads transarterial chemoembolization in GCLM combined trans-arterial infusion therapy for treating primary focus of gastric cancer: a multi-center retrospective study.
Zhao GS; Song YX; Sun JB; Liu S; Xu F; Ma J; Li C; Gao F; Zhou J; Wang RY; Liang SN
Expert Rev Anticancer Ther; 2023; 23(9):1009-1016. PubMed ID: 37475534
[TBL] [Abstract] [Full Text] [Related]
[Next]
